braun tall getty

Report: Alex Rodriguez, Ryan Braun among players MLB seeks to suspend for Biogensis connection


Performance-enhancing drugs loomed large entering the baseball season, amid reports that dozens of players — many of them high-profile stars — could be suspended because of their reported involvement with a clinic that supplied PEDs.

That story just got bigger.

From investigative reporters T.J. Quinn, Pedro Gomez and Mike Fish:

Major League Baseball will seek to suspend about 20 players connected to the Miami-area clinic at the heart of an ongoing performance-enhancing drug scandal, including Alex Rodriguez and Ryan Braun, possibly within the next few weeks, “Outside the Lines” has learned. If the suspensions are upheld, the performance-enhancing drug scandal would be the largest in American sports history.

Tony Bosch, the former director of the Miami-based Biogenesis clinic, is “expected to begin meeting with officials — and naming names — within a week,” according to the report. A source familiar with the case confirmed to The Associated Press early Wednesday morning that Bosch has indeed agreed to talk to MLB about players linked to PEDs, and that Bosch’s information could lead to suspensions. The suspensions could be issued within two weeks, though there’s likely to be an appeals process and that may take a few months. reached both Major League Baseball and the Players’ Association on Tuesday night, but both declined to comment. Terry Fahn, Rodriguez’s publicist as of January, said to contact New York publicist Ron Berkowitz; Berkowitz declined to comment when reached by phone.

MORE: A closer look at the players facing potential suspensions

The commissioner’s office will be seeking 100-game punishments for Braun and A-Rod because they both committed two offenses — the initial doping and then lying to Major League Baseball officials. The typical punishment for first-time performance-enhancing drug offenders is a 50-game suspension.

Nationals left-hander Gio Gonzalez is not a candidate for suspension, according to Quinn, because Bosch is expected to confirm to the investigators that Gio only bought league-approved substances. Some of the other names that were found in the Biogenesis documents: Melky Cabrera, Bartolo Colon, Yasmani Grandal, Nelson Cruz, Francisco Cervelli, Jesus Montero, Jhonny Peralta, Cesar Puello, Fernando Martinez, Everth Cabrera, Fautino de los Santos and Jordan Norberto.

MORE: Why a mass suspension would be a mass fail

The Biogenesis news broke in late January, when it was reported by multiple outlets that Major League Baseball was investigating Bosch under the suspicion that his clinic represented “ground zero” for performance enhancing drugs in Florida, where a disproportionate number of major leaguers grew up, played amateur and college baseball or where they currently make their offseason homes. On January 29, the Miami New Times obtained and published a large portion of the Biogenesis clinic’s records which contained the names of several major leaguers accompanied in many cases by notations which suggested that the players were given performance enhancing drugs. The documents were not conclusive of any player’s use and, in some cases — like with Gio Gonzalez — no connection could be found between the player and any substances which are banned by Major League Baseball.

Immediately after the Miami New Times report came out all of the players involved either denied any involvement with Biogenesis whatsoever or denied that they obtained banned substances.  For example, Gonzalez claims that his father was a patient of Bosch’s. Ryan Braun claims that his attorneys used Bosch as a consultant in his successful 2012 appeal of his PED suspension. Despite the denials, the report and the documents set off a media firestorm which caused Major League Baseball to step up its investigation of the players named therein.

Tigers agree to deal with starter Jordan Zimmermann

Jordan Zimmermann
AP Photo/Pablo Martinez Monsivais

Hey, the hot stove is finally generating some real fire …

CBS Sports’ Jon Heyman reports that the Tigers have agreed to terms on a contract with free agent starter Jordan Zimmermann. It’s a five-year deal worth around $110 million, per Jon Morosi of FOX Sports.

This should have a domino effect on a loaded starting pitching market. David Price, Zack Greinke, Johnny Cueto, Mike Leake, and Jeff Samardzija are just a few of the names still out there.

Zimmermann, 29, posted a 3.66 ERA, 1.21 WHIP, and 164/39 K/BB ratio in 201 2/3 innings this past season for the Nationals. He had a 2.66 ERA in 2014 and threw a no-hitter on the final day of the regular season.

Zimmermann’s free agency is tied to draft pick compensation because he rejected a one-year, $15.8 million qualifying offer from Washington, but the Tigers finished with one of the 10-worst win-loss records in 2015 so their first-round pick in 2016 is protected. Detroit will give up its second-round pick instead.

Video: Statcast’s 10 longest home runs from 2015

Giancarlo Stanton
AP Photo/Joe Skipper

Here’s a pretty good way to finally break out of that turkey-induced Thanksgiving tryptophan coma.

It’s a compilation of the 10 longest home runs from the 2015 season, with’s Statcast technology providing data along the path of each blast …

Tigers in discussions with Jordan Zimmermann

Jordan Zimmermann
AP Photo/Alex Brandon

Jon Morosi of FOX Sports reports that the Tigers are in discussions with free agent starter Jordan Zimmermann. His sources have told him that the talks have become “serious”.

Zimmermann, 29, has a career 3.32 ERA across parts of seven seasons in the majors. He finished fifth in National League Cy Young Award balloting in 2014, finishing with a 2.66 ERA and a 182/29 K/BB ratio over 199 2/3 innings.

Among starters who have amassed at least 1,000 innings since 2009, only Cliff Lee, Dan Haren, Madison Bumgarner, and Zack Greinke have compiled a better strikeout-to-walk ratio than Zimmermann’s 4.09. While he doesn’t have the star power of other free agents such as Greinke or David Price, the Tigers would certainly improve their rotation by bringing him on board.

Blue Jays still focused on upgrading their pitching

Marco Estrada
AP Photo/LM Otero

Having already added Jesse Chavez and J.A. Happ to the mix and re-signing Marco Estrada early in the offseason, Blue Jays interim GM Tony LaCava said the team will continue to pursue pitching upgrades, as Sportsnet’s Ben Nicholson-Smith reports. Nicholson-Smith added that LaCava declined to comment on free agent ace David Price. It is believed that the Jays will not pursue Price and other big-name free agent starting pitchers given their November activity.

The Jays re-signed Estrada to a two-year, $26 million deal on November 13, acquired Chavez from the Athletics in exchange for reliever Liam Hendriks on November 20 and signed Happ to a three-year, $36 million deal on Friday.

Nicholson-Smith notes in a column on Sportsnet that the Jays need to address the bullpen in particular. That is especially true after swapping Hendriks, who had a career-best 2.92 ERA out of the Jays’ bullpen in 2015, for a back-end starting pitcher.